These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7073278)

  • 1. Resistance of Mycobacterium chelonei-like organisms to formaldehyde.
    Hayes PS; McGiboney DL; Band JD; Feeley JC
    Appl Environ Microbiol; 1982 Mar; 43(3):722-4. PubMed ID: 7073278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis.
    Band JD; Ward JI; Fraser DW; Peterson NJ; Silcox VA; Good RC; Ostroy PR; Kennedy J
    J Infect Dis; 1982 Jan; 145(1):9-17. PubMed ID: 7054321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants.
    Carson LA; Petersen NJ; Favero MS; Aguero SM
    Appl Environ Microbiol; 1978 Dec; 36(6):839-46. PubMed ID: 104656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution.
    Swenson JM; Thornsberry C; Silcox VA
    Antimicrob Agents Chemother; 1982 Aug; 22(2):186-92. PubMed ID: 6927280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.
    Woods GL; Hall GS; Schreiber MJ
    J Clin Microbiol; 1986 Apr; 23(4):786-8. PubMed ID: 3700629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Swenson JM; Silcox VA; Good RC
    J Clin Microbiol; 1982 Dec; 16(6):1003-6. PubMed ID: 6298271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
    Wallace RJ; Dalovisio JR; Pankey GA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):611-4. PubMed ID: 526002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.
    Dalovisio JR; Pankey GA
    J Infect Dis; 1978 Mar; 137(3):318-21. PubMed ID: 632627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium chelonei peritonitis due to hematogenous dissemination in a continuous ambulatory peritoneal dialysis patient.
    Selgas R; Muñoz J; Aquella A; Huarte E; Fonseca E; Escuin F; Contreras F
    Am J Kidney Dis; 1987 Aug; 10(2):144-6. PubMed ID: 3605092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis.
    Vera G; Lew SQ
    Am J Nephrol; 1999; 19(5):586-9. PubMed ID: 10575188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritonitis from automated peritoneal dialysis.
    Hamory BH; Neviakias JM; Pearson SK
    Infect Control; 1984 Dec; 5(12):559-61. PubMed ID: 6569854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers.
    Bolan G; Reingold AL; Carson LA; Silcox VA; Woodley CL; Hayes PS; Hightower AW; McFarland L; Brown JW; Petersen NJ
    J Infect Dis; 1985 Nov; 152(5):1013-9. PubMed ID: 4045242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Mycobacterium fortuitum and M. chelonei to sisomicin, gentamicin and tobramycin.
    Casal MJ; Rodriguez FC
    Ann Microbiol (Paris); 1983; 134B(3):451-4. PubMed ID: 6675495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
    Wallace RJ; Jones DB; Wiss K
    Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis.
    Pulliam JP; Vernon DD; Alexander SR; Hartstein AI; Golper TA
    Am J Kidney Dis; 1983 May; 2(6):610-4. PubMed ID: 6846333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M. fortuitum and M. chelonei-fast growing mycobacteria. A review with a case report.
    Ward JM
    Br J Dermatol; 1975 Apr; 92(4):453-9. PubMed ID: 1156561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of Mycobacterium chelonei subspecies chelonei (Mycobacterium borstelense) from pulmonary lesions of 9 patients.
    Tsukamura M; Nakamura E; Kurita I; Nakamura T
    Am Rev Respir Dis; 1973 Sep; 108(3):683-5. PubMed ID: 4745266
    [No Abstract]   [Full Text] [Related]  

  • 18. Biocidal activity of formaldehyde and nonformaldehyde biocides toward Mycobacterium immunogenum and Pseudomonas fluorescens in pure and mixed suspensions in synthetic metalworking fluid and saline.
    Selvaraju SB; Khan IU; Yadav JS
    Appl Environ Microbiol; 2005 Jan; 71(1):542-6. PubMed ID: 15640232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for the care of automated peritoneal dialysis machines: can the risk of peritonitis be reduced?
    Berkelman RL; Band JD; Petersen NJ
    Infect Control; 1984 Feb; 5(2):85-7. PubMed ID: 6559769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.
    Casal MJ; Rodriguez FC; Benavente MC
    Antimicrob Agents Chemother; 1985 Feb; 27(2):282-3. PubMed ID: 3857020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.